Literature DB >> 3621460

Lack of DNA damage or lipid peroxidation measured in vivo in the rat liver following treatment with peroxisomal proliferators.

B M Elliott, C R Elcombe.   

Abstract

This study was undertaken to investigate the hypothesis linking peroxisome proliferation with the production of reactive oxygen species and subsequent DNA damage. Hepatic peroxisomal proliferation was induced in male Wistar-derived rats by the administration of clofibrate, methyl clofenapate, di(2-ethylhexyl)phthalate, or its metabolite mono (2-ethylhexyl)phthalate (MEHP) for periods of up to 28 days. Genotoxicity was monitored using an alkaline elution technique to assay for DNA strandbreaks and cytotoxicity was monitored by measuring lipid peroxidation. Both parameters might be expected to be elevated if peroxisome proliferation is accompanied by an elevated level of oxygen free radicals within the cell. Enzyme measurements made on the livers of the treated rats showed that peroxisomal palmitoyl CoA oxidase activity was markedly increased over control whereas peroxisomal catalase activity was not. In addition, both the cytosolic glutathione peroxidase and superoxide dismutase activities were found to be lowered in the treated animals by up to 50 and 20% respectively. Despite such changes in enzyme activity, no evidence for increases in DNA strandbreaks or lipid peroxidation was obtained with any of the chemicals at any of the time points examined. DNA strandbreaks were also assayed on hepatocytes treated in culture with MEHP (0.5 mM) for 3 days and then exposed to inhibitors of DNA repair for 2 h immediately before assay. Again, no significant increase over controls was observed. Our data suggest that any increase in radical production in the livers of rats exposed to peroxisome proliferators is not large enough to give rise to a biologically significant degree of DNA damage and that the mechanism whereby such chemicals produce liver tumours in certain rodent species may be one other than simply DNA damage due to increased production of radical species.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3621460     DOI: 10.1093/carcin/8.9.1213

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  Juxtaposition of peroxisomes and chromosomes in mitotic hepatocytes following methyl clofenapate administration to rats.

Authors:  A R Soames; J R Foster
Journal:  Int J Exp Pathol       Date:  1994-12       Impact factor: 1.925

Review 2.  Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.

Authors:  Ivan Rusyn; Jeffrey M Peters; Michael L Cunningham
Journal:  Crit Rev Toxicol       Date:  2006-05       Impact factor: 5.635

Review 3.  The PPARα-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions.

Authors:  J Christopher Corton; Jeffrey M Peters; James E Klaunig
Journal:  Arch Toxicol       Date:  2017-12-02       Impact factor: 5.153

4.  No Modifying Effect of Antioxidant N-Acetyl-L-Cysteine on Fenofibrate-induced Hepatocarcinogenesis in Rats.

Authors:  Jihei Nishimura; Yasuaki Dewa; Meilan Jin; Yukie Saegusa; Masaomi Kawai; Sayaka Kemmochi; Keisuke Shimamoto; Tomoaki Harada; Tadashi Itoh; Tomomi Shima; Makoto Shibutani; Kunitoshi Mitsumori
Journal:  J Toxicol Pathol       Date:  2009-12-21       Impact factor: 1.628

Review 5.  Measurement of ploidy and cell proliferation in the rodent liver.

Authors:  J A Styles
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

6.  Changes in expression of cellular oncogenes and endogenous retrovirus-like sequences during hepatocarcinogenesis induced by a peroxisome proliferator.

Authors:  L L Hsieh; H Shinozuka; I B Weinstein
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

7.  Evaluation of toxicogenomics approaches for assessing the risk of nongenotoxic carcinogenicity in rat liver.

Authors:  Johannes Eichner; Clemens Wrzodek; Michael Römer; Heidrun Ellinger-Ziegelbauer; Andreas Zell
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.